Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 September 2025 | Story Lilitha Dingwayo | Photo Lunga Luthuli
Bibi Essop
Bibi Essop, newly elected Universal Access Officer of the Bloemfontein Campus CSRC, celebrates her election as a representative of CUADS and students living with disabilities at the UFS.

The University of the Free State (UFS) community proudly celebrates the appointment of Bibi Essop as the newly elected Campus Student Representative Council Universal Access Officer on the Bloemfontein Campus – a role of immense importance for inclusivity, representation, and student advocacy.

Living with brittle bone syndrome, Essop brings both personal insight and leadership to her portfolio, representing the Centre for Universal Access and Disability Support (CUADS). Her election is not only a personal milestone but also a testament to the university’s growing recognition of the importance of visible leadership by students with disabilities.

By stepping into this position, Essop embodies the empowerment of students who navigate both academic life and unique personal challenges. “This is the pinnacle of my achievements this year, as I have been working towards this for the past three to four years,” she says.

She emphasises that her first priority was to understand the needs of the community she represents. “I had to make sure I know the people I represent, which gave me the opportunity to learn about the other four cohorts on our campus: students with visual impairment, hearing impairment, and learning difficulties, since I am a part of the mobility impairment cohort,” she explains.

The role of Universal Access Officer is vital in ensuring that the needs of students with disabilities remain central to discussions about inclusivity, campus infrastructure, and academic support. Essop is determined to challenge misconceptions about the position. 

“Many people assume my portfolio is restricted to CUADS students only, whereas it is so diverse that it needs to be incorporated in every other portfolio. Accessibility at every event is essential for students living with disabilities,” she says. “Many students do not attend events because they presume that they will not be accommodated.” 

Looking beyond academics, Essop hopes to work closely with fellow CSRC members to ensure inclusivity across all aspects of student life. One initiative she is particularly excited about is Casual Day on 5 September 2025 - a celebration of different disabilities aimed at fostering awareness, education, and integration among all students. 

“The CSRC has reach and influence across all three campuses. By partnering with them, CUADS can amplify its work, ensure consistent messaging, and create opportunities for engagement that are student-driven. This collaboration allows us to step outside of formal support channels and become part of broader campus conversations, events, and initiatives,” says Mosa Moerane who is the liaison, advocacy and awareness officer for CUADS. 

Moerane explains that there are differences in challenges faced by students with disabilities on three campuses. “Bloemfontein, being the largest campus, often presents challenges around scale- serving a higher number of students with diverse needs. South Campus has its own dynamics, with many first-year students who may still be navigating disclosure and adjustment. Qwaqwa students face unique geographical and infrastructural challenges. CUADS responds by tailoring support through assistive technology, academic accommodations, or advocacy for improved accessibility while keeping the student’s lived experience at the centre,” said Moerane.

“The aim is always to make students in Qwaqwa and South Campuses feel as included as those in Bloemfontein. Also having offices at South Campus and Qwaqwa Campus with CUADS Coordinators assists in ensuring that our students are supported similarly to those on Bloemfontein Campus,” she added.

As UFS continues its journey towards greater inclusivity, Essop’s appointment serves as a reminder of the importance of representation across all student cohorts. It affirms that every voice, regardless of background or circumstance, deserves to be heard.

The university congratulates Bibi Essop on this well-deserved achievement. Her leadership represents a step towards ensuring that universal access is not just a policy, but a lived reality for all UFS students. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept